Overview
Oxaprozin is a non-narcotic, non-steroidal anti-inflammatory drug (NSAID), used to relieve the inflammation, swelling, stiffness, and joint pain associated with osteoarthritis and rheumatoid arthritis.
Indication
Used to relieve the inflammation, swelling, stiffness, and joint pain associated with rheumatoid arthritis and osteoarthritis.
Associated Conditions
- Osteoarthritis (OA)
- Rheumatoid Arthritis
- Rheumatoid Arthritis, Juvenile
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2017/11/22 | Phase 1 | Completed | Mochida Pharmaceutical Company, Ltd. |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| California Pharmaceutical LLC | 70332-311 | ORAL | 600 mg in 1 1 | 1/2/2018 | |
| DIRECT RX | 61919-673 | ORAL | 600 mg in 1 1 | 4/19/2019 | |
| Dr. Reddy's Laboratories Limited | 55111-170 | ORAL | 600 mg in 1 1 | 5/28/2019 | |
| Pfizer Laboratories Div Pfizer Inc | 0025-1381 | ORAL | 600 mg in 1 1 | 11/17/2022 | |
| California Pharmaceuticals LLC | 70332-310 | ORAL | 600 mg in 1 1 | 11/3/2017 | |
| St Mary's Medical Park Pharmacy | 60760-092 | ORAL | 600 mg in 1 1 | 8/22/2019 | |
| Amneal Pharmaceuticals NY LLC | 69238-1120 | ORAL | 600 mg in 1 1 | 7/21/2023 | |
| Eon Labs, Inc. | 0185-0141 | ORAL | 600 mg in 1 1 | 5/3/2021 | |
| Bryant Ranch Prepack | 71335-0902 | ORAL | 600 mg in 1 1 | 5/23/2023 | |
| Bryant Ranch Prepack | 71335-2295 | ORAL | 600 mg in 1 1 | 5/3/2021 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| APO-OXAPROZIN | 02243661 | Tablet - Oral | 600 MG | 5/29/2001 | |
| RHOXAL-OXAPROZIN | rhoxalpharma inc | 02243799 | Tablet - Oral | 600 MG | 6/11/2001 |
| DAYPRO | 02027860 | Tablet - Oral | 600 MG | 1/7/1997 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.